Calder E A, Penhale W J, McLeman D, Barnes E W, Irvine W J
Clin Exp Immunol. 1973 Jun;14(2):153-8.
In the presence of normal human lymphocytes, decomplemented sera from twentynine out of thirty-nine patients with Hashimoto thyroiditis caused significant lysis of thyroglobulin-coated chicken red blood cells, as estimated by the release of Cr; the mean% specific Cr release being 14·1 ± 1·9 (SEM). Serum from twenty-one control subjects studied concurrently caused no significant lysis of thyroglobulin-coated chicken red blood cells; the mean% specific Cr release being −1·6±0·7 (SEM). The degree of cytotoxicity correlated with the titre of thyroglobulin antibodies in the serum, determined by tanned red cell haemagglutination. The active component in the Hashimoto serum was localized in the 19S fraction, was unaffected by pre-absorption with anti-human IgM serum, but was neutralized by pre-absorption with anti-human IgG serum. These findings suggest that the cytotoxic activity of serum from patients with Hashimoto thyroiditis is due to the presence of thyroglobulin antibody of the IgG class in the form of complexes, either alone or with antigen. It is postulated that non-specific lymphocytes may play an important role in the pathogenesis of Hashimoto thyroiditis, being activated by the presence in the gland of thyroglobulin antibody, either alone or in the form of complexes attached to thyroid cells.
在正常人淋巴细胞存在的情况下,通过铬的释放量估算,39例桥本甲状腺炎患者中有29例的补体灭活血清导致甲状腺球蛋白包被的鸡红细胞发生显著溶解;特异性铬释放的平均百分比为14.1±1.9(标准误)。同时研究的21名对照受试者的血清未导致甲状腺球蛋白包被的鸡红细胞发生显著溶解;特异性铬释放的平均百分比为-1.6±0.7(标准误)。细胞毒性程度与通过鞣酸红细胞血凝试验测定的血清中甲状腺球蛋白抗体滴度相关。桥本血清中的活性成分定位于19S组分,不受抗人IgM血清预吸收的影响,但可被抗人IgG血清预吸收所中和。这些发现提示,桥本甲状腺炎患者血清的细胞毒性活性是由于存在单独或与抗原形成复合物形式的IgG类甲状腺球蛋白抗体。据推测,非特异性淋巴细胞可能在桥本甲状腺炎的发病机制中起重要作用,被腺体中单独存在或以附着于甲状腺细胞的复合物形式存在的甲状腺球蛋白抗体激活。